Cargando…
Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746757/ https://www.ncbi.nlm.nih.gov/pubmed/36191588 http://dx.doi.org/10.1097/CM9.0000000000002243 |
| _version_ | 1784849435839168512 |
|---|---|
| author | Tang, Yun Yang, Xiaobo Shu, Huaqing Yu, Yuan Xu, Jiqian Pan, Shangwen Zou, Xiaojing Yuan, Shiying Shang, You |
| author_facet | Tang, Yun Yang, Xiaobo Shu, Huaqing Yu, Yuan Xu, Jiqian Pan, Shangwen Zou, Xiaojing Yuan, Shiying Shang, You |
| author_sort | Tang, Yun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9746757 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97467572022-12-16 Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study Tang, Yun Yang, Xiaobo Shu, Huaqing Yu, Yuan Xu, Jiqian Pan, Shangwen Zou, Xiaojing Yuan, Shiying Shang, You Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-09-05 2022-09-28 /pmc/articles/PMC9746757/ /pubmed/36191588 http://dx.doi.org/10.1097/CM9.0000000000002243 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Tang, Yun Yang, Xiaobo Shu, Huaqing Yu, Yuan Xu, Jiqian Pan, Shangwen Zou, Xiaojing Yuan, Shiying Shang, You Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study |
| title | Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study |
| title_full | Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study |
| title_fullStr | Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study |
| title_full_unstemmed | Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study |
| title_short | Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study |
| title_sort | remimazolam besylate for sedation of postoperative patients in intensive care units: a phase i, open label, dose-finding study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746757/ https://www.ncbi.nlm.nih.gov/pubmed/36191588 http://dx.doi.org/10.1097/CM9.0000000000002243 |
| work_keys_str_mv | AT tangyun remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT yangxiaobo remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT shuhuaqing remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT yuyuan remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT xujiqian remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT panshangwen remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT zouxiaojing remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT yuanshiying remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy AT shangyou remimazolambesylateforsedationofpostoperativepatientsinintensivecareunitsaphaseiopenlabeldosefindingstudy |